Premium
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
VANCOUVER, British Columbia and BOSTON, Dec. 03, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today...
VANCOUVER, British Columbia and BOSTON, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today...
VANCOUVER, British Columbia and BOSTON, Oct. 17, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) is pleased...
VANCOUVER, British Columbia and BOSTON, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today...
VANCOUVER, British Columbia and BOSTON, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today...
New name reflects evolution of company from development-stage biotech to innovator in predictive medicine TORONTO, Sept. 27 /PRNewswire-FirstCall/ -- IMI International Medical Innovations Inc...
CDN$10 million/US$8.2 million financing positions IMI for future anticipated growth TORONTO, Aug. 30 /PRNewswire-FirstCall/ -- Predictive medicine company IMI International Medical Innovations...
Enters into agreement for CDN$10 million/US$8.2 million TORONTO, Aug. 18 /PRNewswire-FirstCall/ -- Predictive medicine company IMI International Medical Innovations Inc. (TSX: IMI; Amex: IME...
- Major ColorectAlert(TM) study with U.S. National Cancer Institute - 25,000-participant PREPARE study underway in life insurance testing market - Expanded scientific validation for PREVU(x...
Allstate teams up with IMI and McNeil Consumer Healthcare for non-invasive risk assessments TORONTO, Aug. 2 /PRNewswire-FirstCall/ -- Blood tests today, skin tests tomorrow. Allstate Life...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.015 | 0.015 | 0.015 | 0 | 0 | CS |
| 4 | 0 | 0 | 0.015 | 0.015 | 0.015 | 0 | 0 | CS |
| 12 | 0 | 0 | 0.015 | 0.015 | 0.015 | 0 | 0 | CS |
| 26 | 0 | 0 | 0.015 | 0.015 | 0.015 | 0 | 0 | CS |
| 52 | -0.085 | -85 | 0.1 | 0.1 | 0.01 | 2782 | 0.03654094 | CS |
| 156 | -0.455 | -96.8085106383 | 0.47 | 0.56 | 0.01 | 4263 | 0.24973857 | CS |
| 260 | -0.04 | -72.7272727273 | 0.055 | 1.44 | 0.01 | 96377 | 0.08131486 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
